Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00433706
Status:
COMPLETED
Last Update Posted:
2016-12-13
First Post:
2007-02-08
Brief Title:
Image Guided Radiation Therapy For Prostate Cancer
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Study Overview
Official Title:
Economic Evaluation of Image Guided Radiation Therapy For Prostate Cancer
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
During the 7 to 8 weeks of conformal radiotherapy for prostate carcinoma the prostate has an intra-pelvic motion which is not detectable by the conventional portal imaging This prostate motion may lead to a mistargeting which possibly decreases the local control On the other hand the new 3D on board imaging 3D OBI allows to localize the target but is expensive The costeffectiveness ratio is not well established as well as the frequency of using such imaging during the course of radiation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| IGRT-P | None | None | None |